Consortium program with the purpose of organizing serveral non-commercial clinical trials and follow-up research projects in respect of Covid19 vaccines in order to generate information and data that might be useful to patients, the clinical practice and/or policy decision makers.

Project Details

Description

BelCoVac brings together all the clinical studies on COVID-19 vaccination in different vulnerable populations (e.g. elderly people, cancer patients, kidney transplant patients, kidney dialysis patients, lung transplant patients,...). The virology lab of ITM is providing all the readouts of the neutralizing antibody capacity in live-virus neutralization tests with all coronavirus variants of concern.
AcronymBelCoVac
StatusActive
Effective start/end date18/01/2117/01/23